{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:36:58Z","timestamp":1770241018515,"version":"3.49.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1397,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ALF-agreement","award":["ALFGBG-721961"],"award-info":[{"award-number":["ALFGBG-721961"]}]},{"name":"Swedish Heart Lung Foundation","award":["20170453"],"award-info":[{"award-number":["20170453"]}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20170453"],"award-info":[{"award-number":["20170453"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to evaluate the outcome and prognostic factors in patients with dilated cardiomyopathy (DCM) and long-standing heart failure (LDCM) vs. recent-onset heart failure (RODCM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We compared 2019 patients with RODCM (duration &amp;lt;6 months, mean age 58.6 years, 70.7% male) with 1714 patients with LDCM (duration \u22656 months, median duration 3.5 years, mean age 62.5 years, 73.7% male) included in the Swedish Heart Failure Registry in the years 2003\u201316. Outcome measures were all-cause, cardiovascular (CV), and non-CV death and hospitalizations; heart transplantation; and a combined outcome of all-cause death, heart transplantation, or heart failure (HF) hospitalization. Multivariable risk factor analyses were performed for the combined endpoint. All outcomes were more frequent in LDCM than in RODCM. The multivariable-adjusted hazard ratios (HRs) (95% confidence interval) for LDCM vs. RODCM were 1.56 (1.34\u20131.82), P &amp;lt; 0.0001, for all-cause death over a median follow-up of 4.2 and 5.0 years, respectively; 1.67 (1.36\u20132.05), P &amp;lt; 0.0001, for CV death; 2.12 (1.14\u20133.91), P &amp;lt; 0.0001, for heart transplantation; 1.36 (1.21\u20131.53), P &amp;lt; 0.0001, for HF hospitalization; and 1.37 (1.24\u20131.52), P &amp;lt; 0.0001, for the combined outcome. A propensity score-matched analysis yielded similar results. CV death was the main cause of mortality in LDCM and was higher in LDCM than in RODCM (P &amp;lt; 0.0001). Almost all co-morbidities were significantly more frequent in LDCM than in RODCM, and the mean number of co-morbidities increased significantly with increased duration of disease, also after age adjustment. Age, New York Heart Association functional class, ejection fraction, and left bundle branch block were prognostically adverse. The only co-morbidity associated with the combined outcome regardless of HF duration was diabetes, in LDCM [HR 1.34 (1.15\u20131.56), P = 0.0002] and in RODCM [HR 1.29 (1.04\u20131.59), P = 0.018]. Male sex [HR 1.38 (1.18\u20131.63), P &amp;lt; 0.0001] and aspirin use [HR 1.33 (1.14\u20131.55), P = 0.0004] carried increased risk only in RODCM. Heart rate \u226575 b.p.m. [HR 1.20 (1.04\u20131.37), P = 0.01], atrial fibrillation [HR 1.24 (1.08\u20131.42), P = 0.0024], musculoskeletal or connective tissue disorder [HR 1.36 (1.13\u20131.63), P = 0.0014], and diuretic therapy [HR 1.40 (1.17\u20131.67), P = 0.0002] were prognostically adverse only in LDCM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This nationwide study of patients with DCM demonstrates that longer disease duration is associated with worse prognosis. Co-morbidities are more common in long-standing HF than in recent-onset HF and are associated with worse outcome. With the increased survival seen in the last decades, our results highlight the importance of careful attention to co-morbid conditions in patients with DCM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13816","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T01:10:05Z","timestamp":1644282605000},"page":"1294-1303","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic Differences in Long-Standing vs. Recent-Onset Dilated Cardiomyopathy"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-7868","authenticated-orcid":false,"given":"Jonas","family":"Silverdal","sequence":"first","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Sj\u00f6land","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldina","family":"Pivodic","sequence":"additional","affiliation":[{"name":"Statistiska Konsultgruppen , Gothenburg ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Dahlstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Department of Health, Medicine and Caring Sciences, Link\u00f6ping University , Link\u00f6ping ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Entela","family":"Bollano","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"2026012114170759700_ehf213816-bib-0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026012114170759700_ehf213816-bib-0002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","article-title":"Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF","volume":"7","author":"Balmforth","year":"2019","journal-title":"JACC Heart Failure"},{"key":"2026012114170759700_ehf213816-bib-0003","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"2026012114170759700_ehf213816-bib-0004","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report\u20142018; focus theme: multiorgan transplantation","volume":"37","author":"Khush","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2026012114170759700_ehf213816-bib-0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ahj.2012.06.009","article-title":"The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation","volume":"164","author":"Teeter","year":"2012","journal-title":"Am Heart J"},{"key":"2026012114170759700_ehf213816-bib-0006","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijcard.2010.01.011","article-title":"Heart failure etiology impacts survival of patients with heart failure","volume":"149","author":"Pecini","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026012114170759700_ehf213816-bib-0008","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/ejhf.1914","article-title":"Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy","volume":"22","author":"Merlo","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0009","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12872-021-02124-0","article-title":"Temporal trends in outcome and patient characteristics in dilated cardiomyopathy, data from the Swedish Heart Failure Registry 2003\u20132015","volume":"21","author":"Sjoland","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012114170759700_ehf213816-bib-0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00125-010-1965-8","article-title":"Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes","volume":"54","author":"Nichols","year":"2011","journal-title":"Diabetologia"},{"key":"2026012114170759700_ehf213816-bib-0011","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N Engl J Med"},{"key":"2026012114170759700_ehf213816-bib-0012","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ehf2.12568","article-title":"Prognostic impact over time of ischaemic heart disease vs. non-ischaemic heart disease in heart failure","volume":"7","author":"Silverdal","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/eurjhf\/hfs139","article-title":"Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial","volume":"15","author":"Mentz","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0014","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00392-013-0589-7","article-title":"Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy","volume":"102","author":"Frankenstein","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"2026012114170759700_ehf213816-bib-0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurjhf\/hfp175","article-title":"Heart failure registry: a valuable tool for improving the management of patients with heart failure","volume":"12","author":"Jonsson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009734.2018.1490831","article-title":"The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure","volume":"124","author":"Savarese","year":"2019","journal-title":"Ups J Med Sci"},{"key":"2026012114170759700_ehf213816-bib-0017","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"2026012114170759700_ehf213816-bib-0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143084","article-title":"Diabetes prevalence in Sweden at present and projections for year 2050","volume":"10","author":"Andersson","year":"2015","journal-title":"PLoS One"},{"key":"2026012114170759700_ehf213816-bib-0019","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","article-title":"Diabetes and idiopathic cardiomyopathy: a nationwide case-control study","volume":"26","author":"Bertoni","year":"2003","journal-title":"Diabetes Care"},{"key":"2026012114170759700_ehf213816-bib-0020","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.781","article-title":"Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry","volume":"19","author":"Lund","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0021","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.119.043012","article-title":"Association between use of primary-prevention implantable cardioverter-defibrillators and mortality in patients with heart failure: a prospective propensity score-matched analysis from the Swedish Heart Failure Registry","volume":"140","author":"Schrage","year":"2019","journal-title":"Circulation"},{"key":"2026012114170759700_ehf213816-bib-0022","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2011.05.033","article-title":"Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study","volume":"58","author":"McNamara","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026012114170759700_ehf213816-bib-0023","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.1216","article-title":"Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy","volume":"20","author":"Halliday","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0024","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/ejhf.1548","article-title":"The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics","volume":"21","author":"McMurray","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0025","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012114170759700_ehf213816-bib-0026","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10741-020-09995-z","article-title":"Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients","volume":"27","author":"Kapelios","year":"2020","journal-title":"Heart Fail Rev"},{"key":"2026012114170759700_ehf213816-bib-0027","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2017.09.193","article-title":"Association of diuretic treatment at hospital discharge in patients with heart failure with all-cause short- and long-term mortality: a propensity score-matched analysis from SwedeHF","volume":"257","author":"Paren","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026012114170759700_ehf213816-bib-0028","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/CIRCHEARTFAILURE.114.001730","article-title":"Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry","volume":"8","author":"Alehagen","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026012114170759700_ehf213816-bib-0029","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13816","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13816","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/2\/1294\/65375302\/eschf_9_2_1294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/2\/1294\/65375302\/eschf_9_2_1294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:20:36Z","timestamp":1769023236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/2\/1294\/8326227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,7]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13816","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"2021-05-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}